Abstract:Advanced MaterialsVolume 23, Issue 12 p. H84-H89 Communication “Advanced Healthcare Materials” RGD-Modified PEG-PAMAM-DOX Conjugate: In Vitro and In Vivo Targeting to Both Tumor Neovascular Endothelial Cells and Tumor Cells Saijie Zhu, Saijie Zhu Department of Pharmaceutics, Key Laboratory of Smart Drug Delivery, Ministry of Education and PLA School of Pharmacy, Fudan University, 826 Zhangheng Road, 201203 Shanghai, P. R. ChinaSearch for more papers by this authorLili Qian, Lili Qian Department of Pharmaceutics, Key Laboratory of Smart Drug Delivery, Ministry of Education and PLA School of Pharmacy, Fudan University, 826 Zhangheng Road, 201203 Shanghai, P. R. ChinaSearch for more papers by this authorMinghuang Hong, Minghuang Hong Department of Pharmaceutics, Key Laboratory of Smart Drug Delivery, Ministry of Education and PLA School of Pharmacy, Fudan University, 826 Zhangheng Road, 201203 Shanghai, P. R. ChinaSearch for more papers by this authorLihong Zhang, Lihong Zhang Department of Pharmaceutics, Key Laboratory of Smart Drug Delivery, Ministry of Education and PLA School of Pharmacy, Fudan University, 826 Zhangheng Road, 201203 Shanghai, P. R. ChinaSearch for more papers by this authorYuanying Pei, Yuanying Pei Department of Pharmaceutics, Key Laboratory of Smart Drug Delivery, Ministry of Education and PLA School of Pharmacy, Fudan University, 826 Zhangheng Road, 201203 Shanghai, P. R. ChinaSearch for more papers by this authorYanyan Jiang, Corresponding Author Yanyan Jiang [email protected] Department of Pharmaceutics, Key Laboratory of Smart Drug Delivery, Ministry of Education and PLA School of Pharmacy, Fudan University, 826 Zhangheng Road, 201203 Shanghai, P. R. ChinaDepartment of Pharmaceutics, Key Laboratory of Smart Drug Delivery, Ministry of Education and PLA School of Pharmacy, Fudan University, 826 Zhangheng Road, 201203 Shanghai, P. R. China.Search for more papers by this author Saijie Zhu, Saijie Zhu Department of Pharmaceutics, Key Laboratory of Smart Drug Delivery, Ministry of Education and PLA School of Pharmacy, Fudan University, 826 Zhangheng Road, 201203 Shanghai, P. R. ChinaSearch for more papers by this authorLili Qian, Lili Qian Department of Pharmaceutics, Key Laboratory of Smart Drug Delivery, Ministry of Education and PLA School of Pharmacy, Fudan University, 826 Zhangheng Road, 201203 Shanghai, P. R. ChinaSearch for more papers by this authorMinghuang Hong, Minghuang Hong Department of Pharmaceutics, Key Laboratory of Smart Drug Delivery, Ministry of Education and PLA School of Pharmacy, Fudan University, 826 Zhangheng Road, 201203 Shanghai, P. R. ChinaSearch for more papers by this authorLihong Zhang, Lihong Zhang Department of Pharmaceutics, Key Laboratory of Smart Drug Delivery, Ministry of Education and PLA School of Pharmacy, Fudan University, 826 Zhangheng Road, 201203 Shanghai, P. R. ChinaSearch for more papers by this authorYuanying Pei, Yuanying Pei Department of Pharmaceutics, Key Laboratory of Smart Drug Delivery, Ministry of Education and PLA School of Pharmacy, Fudan University, 826 Zhangheng Road, 201203 Shanghai, P. R. ChinaSearch for more papers by this authorYanyan Jiang, Corresponding Author Yanyan Jiang [email protected] Department of Pharmaceutics, Key Laboratory of Smart Drug Delivery, Ministry of Education and PLA School of Pharmacy, Fudan University, 826 Zhangheng Road, 201203 Shanghai, P. R. ChinaDepartment of Pharmaceutics, Key Laboratory of Smart Drug Delivery, Ministry of Education and PLA School of Pharmacy, Fudan University, 826 Zhangheng Road, 201203 Shanghai, P. R. China.Search for more papers by this author First published: 01 March 2011 https://doi.org/10.1002/adma.201003944Citations: 109Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat Graphical Abstract A novel multifunctional drug–polymer conjugate is prepared. RGD peptide is used to actively target the drug delivery system to tumor neovascular endothelial cells and tumor cells, while the PEG-PAMAM polymeric carrier permits passive targeting to the tumor site by the enhanced permeability and retention (EPR) effect. Controlled release of the anticancer drug doxorubicin is also achieved via acid-sensitive cis-aconityl linkage. Supporting Information Detailed facts of importance to specialist readers are published as ”Supporting Information”. Such documents are peer-reviewed, but not copy-edited or typeset. They are made available as submitted by the authors. Filename Description adma_201003944_sm_suppl.pdf851 KB suppl Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article. References 1 W. Cai, G. Niu, X. Chen, Curr. Pharm. Des. 2008, 14, 2943. 10.2174/138161208786404308 CASPubMedWeb of Science®Google Scholar 2 K. Temming, R. M. Schiffelers, G. Molema, R. J. Kok, Drug Resist. Updates 2005, 8, 381. 10.1016/j.drup.2005.10.002 CASPubMedWeb of Science®Google Scholar 3 M. P. Borgman, O. Aras, S. Geyser-Stoops, E. A. Sausville, H. Ghandehari, Mol. Pharmaceutics 2009, 6, 1836. 10.1021/mp900134c CASPubMedWeb of Science®Google Scholar 4 M. Oba, K. Aoyagi, K. Miyata, Y. Matsumoto, K. Itaka, N. Nishiyama, Y. Yamasaki, H. Koyama, K. Kataoka, Mol. Pharmaceutics 2008, 5, 1080. 10.1021/mp800070s CASPubMedWeb of Science®Google Scholar 5 Z. Liu, S. Liu, G. Niu, F. Wang, S. Liu, X. Chen, Mol. Imaging 2010, 9, 21. CASPubMedWeb of Science®Google Scholar 6 S. Zhu, M. Hong, L. Zhang, G. Tang, Y. Jiang, Y. Pei, Pharm. Res. 2010, 27, 161. 10.1007/s11095-009-9992-1 CASPubMedWeb of Science®Google Scholar 7 S. Zhu, M. Hong, G. Tang, L. Qian, J. Lin, Y. Jiang, Y. Pei, Biomaterials 2010, 31, 1360. 10.1016/j.biomaterials.2009.10.044 CASPubMedWeb of Science®Google Scholar 8 D. B. Leeper, K. Engin, A. J. Thistlethwaite, H. D. Hitchon, J. D. Dover, D. J. Li, L. Tupchong, Int. J. Radiat. Oncol. Biol. Phys. 1994, 28, 935. 10.1016/0360-3016(94)90114-7 CASPubMedWeb of Science®Google Scholar 9 A. S. E. Ojugo, P. M. J. McSheehy, D. J. O. McIntyre, C. McCoy, M. Stubbs, M. O. Leach, I. R. Judson, J. R. Griffiths, NMR Biomed. 1999, 12, 495. 10.1002/(SICI)1099-1492(199912)12:8<495::AID-NBM594>3.0.CO;2-K CASPubMedWeb of Science®Google Scholar 10 R. van Sluis, Z. M. Bhujwalla, N. Raghunand, P. Ballesteros, J. Alvarez, S. Cerdán, J. P. Galons, R. J. Gillies, Magn. Reson. Med. 1999, 41, 743. 10.1002/(SICI)1522-2594(199904)41:4<743::AID-MRM13>3.0.CO;2-Z CASPubMedWeb of Science®Google Scholar 11 J. Liu, J. I. Shapiro, Biol. Res. Nurs. 2003 , 5, 117. 10.1177/1099800403256860 PubMedGoogle Scholar 12 J. Z. Du, T. M. Sun, W. J. Song, J. Wu, J. Wang, Angew. Chem. Int. Ed. 2010, 49, 3621. 10.1002/anie.200907210 CASPubMedWeb of Science®Google Scholar 13 R. Kluger, C. H. Lam, J. Am. Chem. Soc. 1978, 100, 2191. 10.1021/ja00475a033 CASWeb of Science®Google Scholar 14 D. Q. McNerny, J. F. Kukowska-Latallo, D. G. Mullen, J. M. Wallace, A. M. Desai, R. Shukla, B. Huang, M. M. Banaszak Holl, J. R. Baker, Bioconjugate Chem. 2009, 20, 1853. 10.1021/bc900217h CASPubMedWeb of Science®Google Scholar 15 W. Lu, Q. Sun, J. Wan, Z. She, X. G. Jiang, Cancer Res. 2006, 66, 11878. 10.1158/0008-5472.CAN-06-2354 CASPubMedWeb of Science®Google Scholar 16 N. Nasongkla, X. Shuai, H. Ai, B. D. Weinberg, J. Pink, D. A. Boothman, J. Gao, Angew. Chem. Int. Ed. 2004, 43, 6323. 10.1002/anie.200460800 CASPubMedWeb of Science®Google Scholar 17 R. M. Schiffelers, G. A. Koning, T. L. ten Hagen, M. H. Fens, A. J. Schraa, A. P. Janssen, P. J. Kok, G. Molema, G. Storm, J. Controlled Release 2003, 91, 115. 10.1016/S0168-3659(03)00240-2 CASPubMedWeb of Science®Google Scholar 18 A. K. Singh, B. S. Kasinath, E. J. Lewis. Biochim. Biophys. Acta 1992, 1120, 337. 10.1016/0167-4838(92)90257-E CASPubMedWeb of Science®Google Scholar 19 O. P. Perumal, R. Inapagolla, S. Kannan, R. M. Kannan, Biomaterials 2008, 29, 3469. 10.1016/j.biomaterials.2008.04.038 CASPubMedWeb of Science®Google Scholar 20 M. Hong, S. Zhu, Y. Jiang, G. Tang, Y. Pei, J. Controlled Release 2009, 133, 96. 10.1016/j.jconrel.2008.09.005 CASPubMedWeb of Science®Google Scholar 21 N. Kamaly, T. Kalber, M. Thanou, J. D. Bell, A. D. Miller, Bioconjugate Chem. 2009, 20, 648. 10.1021/bc8002259 CASPubMedWeb of Science®Google Scholar 22 S. Samanta, R. Sistla, A. Chaudhuri, Biomaterials 2010, 31, 1787. 10.1016/j.biomaterials.2009.10.027 CASPubMedWeb of Science®Google Scholar 23 D. H. Yu, Q. Lu, J. Xie, C. Fang, H. Z. Chen, Biomaterials 2010, 31, 2278. 10.1016/j.biomaterials.2009.11.047 CASPubMedWeb of Science®Google Scholar 24 Q. Cao, Z. Li, K Chen, Z. Wu, L. He, N. Neamati, X. Chen, Eur. J. Nucl. Med. Mol. Imaging 2008, 35, 1489. 10.1007/s00259-008-0744-y CASPubMedWeb of Science®Google Scholar 25 A. Nanda, B. St Croix, Curr. Opin. Oncol. 2004, 16, 44. 10.1097/00001622-200401000-00009 CASPubMedWeb of Science®Google Scholar 26 R. Tomlinson, J. Heller, S. Brocchini, R. Duncan, Bioconjugate Chem. 2003, 14, 1096. 10.1021/bc030028a CASPubMedWeb of Science®Google Scholar 27 X. B. Xiong, Y. Huang, W. L. Lu, X. Zhang, H. Zhang, T. Nagai, Q. Zhang, J. Controlled Release 2005, 107, 262. 10.1016/j.jconrel.2005.03.030 CASPubMedWeb of Science®Google Scholar Citing Literature Volume23, Issue12March 25, 2011Pages H84-H89 ReferencesRelatedInformation

Abstract:NanomedicineVol. 16, No. 17 EditorialObstacles impeding the development of nanocarriers for anticancer drugsLingshan Liu & Hongjing DouLingshan Liu https://orcid.org/0000-0002-0176-1464The State Key Laboratory of Metal Matrix Composites, School of Materials Science & Engineering, Shanghai Jiao Tong University, Shanghai 200240, PR ChinaSearch for more papers by this author & Hongjing Dou *Author for correspondence: E-mail Address: hjdou@sjtu.edu.cnhttps://orcid.org/0000-0001-5850-9174The State Key Laboratory of Metal Matrix Composites, School of Materials Science & Engineering, Shanghai Jiao Tong University, Shanghai 200240, PR ChinaSearch for more papers by this authorPublished Online:18 Jun 2021https://doi.org/10.2217/nnm-2021-0101AboutSectionsView ArticleView Full TextPDF/EPUB ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareShare onFacebookTwitterLinkedInReddit View articleKeywords: endocytosismononuclear phagocytic systemnanomedicineprotein coronatumor penetrationReferences1. Sung H, Ferlay J, Siegel RL et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. doi:10.3322/caac.21660 (2021) (Epub ahead of print).Crossref, Medline, Google Scholar2. Miller KD, Nogueira L, Mariotto AB et al. Cancer treatment and survivorship statistics, 2019. CA Cancer J. Clin. 69(5), 363–385 (2019).Crossref, Medline, Google Scholar3. Youn YS, Bae YH. Perspectives on the past, present, and future of cancer nanomedicine. Adv. Drug Deliv. Rev. 130, 3–11 (2018).Crossref, Medline, CAS, Google Scholar4. Sun T, Zhang YS, Pang B, Hyun DC, Yang M, Xia Y. Engineered nanoparticles for drug delivery in cancer therapy. Angew. Chem. Int. Ed. Engl. 53(46), 12320–12364 (2014).Medline, CAS, Google Scholar5. Xing R, Liu K, Jiao T et al. An injectable self-assembling collagen-gold hybrid hydrogel for combinatorial antitumor photothermal/photodynamic therapy. Adv. Mater. 28(19), 3669–3676 (2016).Crossref, Medline, CAS, Google Scholar6. Liu Y, Bhattarai P, Dai Z, Chen X. Photothermal therapy and photoacoustic imaging via nanotheranostics in fighting cancer. Chem. Soc. Rev. 48(7), 2053–2108 (2019).Crossref, Medline, CAS, Google Scholar7. Karimi M, Ghasemi A, Sahandi Zangabad P et al. Smart micro/nanoparticles in stimulus-responsive drug/gene delivery systems. Chem. Soc. Rev. 45(5), 1457–1501 (2016).Crossref, Medline, CAS, Google Scholar8. Fan W, Yung B, Huang P, Chen X. Nanotechnology for multimodal synergistic cancer therapy. Chem. Rev. 117(22), 13566–13638 (2017).Crossref, Medline, CAS, Google Scholar9. Wilhelm S, Tavares A, Dai QEA. Analysis of nanoparticle delivery to tumors. Nat. Rev. Mater. 1(5), 16014 (2016).Crossref, CAS, Google Scholar10. Shi J, Kantoff PW, Wooster R, Farokhzad OC. Cancer nanomedicine: progress, challenges and opportunities. Nat. Rev. Cancer 17(1), 20–37 (2017).Crossref, Medline, CAS, Google Scholar11. Khawar IA, Kim JH, Kuh HJ. Improving drug delivery to solid tumors: priming the tumor microenvironment. J. Control. Release 201, 78–89 (2015).Crossref, Medline, CAS, Google Scholar12. Maeda H, Nakamura H, Fang J. The EPR effect for macromolecular drug delivery to solid tumors: improvement of tumor uptake, lowering of systemic toxicity, and distinct tumor imaging in vivo. Adv. Drug Deliv. Rev. 65(1), 71–79 (2013).Crossref, Medline, CAS, Google Scholar13. Nicolas J, Mura S, Brambilla D, Mackiewicz N, Couvreur P. Design, functionalization strategies and biomedical applications of targeted biodegradable/biocompatible polymer-based nanocarriers for drug delivery. Chem. Soc. Rev. 42(3), 1147–1235 (2013).Crossref, Medline, CAS, Google Scholar14. Lv Y, Xu C, Zhao X et al. Nanoplatform assembled from a CD44-targeted prodrug and smart liposomes for dual targeting of tumor microenvironment and cancer cells. ACS Nano 12(2), 1519–1536 (2018).Crossref, Medline, CAS, Google Scholar15. Cai R, Chen C. The crown and the scepter: roles of the protein corona in nanomedicine. Adv. Mater. 31(45), 1805740 (2019).Crossref, CAS, Google Scholar16. Rosenblum D, Joshi N, Tao W, Karp JM, Peer D. Progress and challenges towards targeted delivery of cancer therapeutics. Nat. Commun. 9(1), 1410 (2018).Crossref, Medline, Google Scholar17. Owens DE 3rd, Peppas NA. Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles. Int. J. Pharm. 307(1), 93–102 (2006).Crossref, Medline, CAS, Google Scholar18. Blanco E, Shen H, Ferrari M. Principles of nanoparticle design for overcoming biological barriers to drug delivery. Nat. Biotechnol. 33(9), 941–951 (2015).Crossref, Medline, CAS, Google Scholar19. Zou Y, Ito S, Yoshino F, Suzuki Y, Zhao L, Komatsu N. Polyglycerol grafting shields nanoparticles from protein corona formation to avoid macrophage uptake. ACS Nano 14(6), 7216–7226 (2020).Crossref, Medline, CAS, Google Scholar20. Rudnick SI, Lou J, Shaller CC et al. Influence of affinity and antigen internalization on the uptake and penetration of Anti-HER2 antibodies in solid tumors. Cancer Res. 71(6), 2250–2259 (2011).Crossref, Medline, CAS, Google Scholar21. Chauhan VP, Stylianopoulos T, Martin JD et al. Normalization of tumour blood vessels improves the delivery of nanomedicines in a size-dependent manner. Nat. Nanotechnol. 7(6), 383–388 (2012).Crossref, Medline, CAS, Google Scholar22. Donahue ND, Acar H, Wilhelm S. Concepts of nanoparticle cellular uptake, intracellular trafficking, and kinetics in nanomedicine. Adv. Drug Deliv. Rev. 143, 68–96 (2019).Crossref, Medline, CAS, Google Scholar23. Kinnear C, Moore TL, Rodriguez-Lorenzo L, Rothen-Rutishauser B, Petri-Fink A. Form follows function: nanoparticle shape and its implications for nanomedicine. Chem. Rev. 117(17), 11476–11521 (2017).Crossref, Medline, CAS, Google Scholar24. Behzadi S, Serpooshan V, Tao W et al. Cellular uptake of nanoparticles: journey inside the cell. Chem. Soc. Rev. 46(14), 4218–4244 (2017).Crossref, Medline, CAS, Google Scholar25. Kirpotin DB, Drummond DC, Shao Y et al. Antibody targeting of long-circulating lipidic nanoparticles does not increase tumor localization but does increase internalization in animal models. Cancer Res. 66(13), 6732–6740 (2006).Crossref, Medline, CAS, Google Scholar26. Hühn D, Kantner K, Geidel C et al. Polymer-coated nanoparticles interacting with proteins and cells: focusing on the sign of the net charge. ACS Nano 7(4), 3253–3263 (2013).Crossref, Medline, CAS, Google ScholarFiguresReferencesRelatedDetails Vol. 16, No. 17 Follow us on social media for the latest updates Metrics Downloaded 45 times History Received 13 March 2021 Accepted 29 March 2021 Published online 18 June 2021 Published in print July 2021 Information© 2021 Future Medicine LtdKeywordsendocytosismononuclear phagocytic systemnanomedicineprotein coronatumor penetrationAuthor contributionsL Liu: substantial contribution to the conception or design of the work; or the acquisition, analysis or interpretation of data for the work; and drafting the work or revising it critically for important intellectual content; H Dou: final approval of the version to be published; and agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.Financial & competing interests disclosureThe authors wish to gratefully acknowledge financial support from the National Natural Science Foundation of China (21871180), the Program for Professor of Special Appointment (Eastern Scholar) at Shanghai Institutions of Higher Learning (SHDP201802), the ‘Shuguang Program’ supported by the Shanghai Municipal Education Commission (17SG12), the Science and Technology Commission of Shanghai Municipality (18520710300 and 17ZR1404100) and Biomedical Interdisciplinary Research Foundation of SJTU (YG2019QNB34). The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.No writing assistance was utilized in the production of this manuscript.PDF download

Introducing the Molecular Pharmaceutics Virtual Special Issue on “advances in Molecular Pharmaceutical Research from Asia”

Beyond the Great Wall: Recent Advances in Molecular Pharmaceutics Research in China

Celebrating Women in the Pharmaceutical Sciences.

On the Role of Nanocarriers in Oral Drug Delivery

Simplifying Submission Requirements for the Journal of Medicinal Chemistry

Keeping Nanomedicine on Target

In This Issue, Volume 14, Issue 12

Translational Research: Bridging the Gap Between Fundamental Research and the Clinic

Corrrection to Discovery of Tetrahydropyrazolopyrimidine Carboxamide Derivatives As Potent and Orally Active Novel Antitubercular Agents

In This Issue, Volume 10, Issue 8

Voices in Molecular Pharmaceutics: Meet Dr. Weijun Wei Who is Developing Theranostic Nuclear Medicine Agents for Clinical Use

RGD-modified PEG-PAMAM-DOX Conjugate: in Vitro and in Vivo Targeting to Both Tumor Neovascular Endothelial Cells and Tumor Cells.

Innovative Pharmaceutical Development Based on Unique Properties of Nanoscale Delivery Formulation.

Sonotheranostics and Sonogenetics Special Issue

Obstacles Impeding the Development of Nanocarriers for Anticancer Drugs

New Trends in Virtual Screening

Copolymer Technology for Advanced Nanomedicine

In This Issue, Volume 12, Issue 11

Antibody-Based Imaging and Therapy for Precision Medicine

Correction to “A Carrier-Free Nanomedicine Enables Apoptosis-Ferroptosis Synergistic Breast Cancer Therapy by Targeting Subcellular Organelles”